RxDoctor Payments Data

Amanda Ramsey

Family · Orlando, FLNPI 1386006757

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AstraZeneca at 37.3% of the total. 2025 is the largest year on record at $600, 2.5 times the $242 reported in 2021.

$2,093in general payments, 2019–2025

Across 106 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$781
  • Novo Nordisk$482
  • AbbVie$318
  • Kowa Pharmaceuticals America, Inc.$78
  • Lilly USA, LLC$71
  • Abbott$68
  • plus $296 from 11 others

What the payments were for

  • Food & beverage$2,093100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,093 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Other family in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →